Kinase signaling cascades: an updated mechanistic landscape
Chemical Science · 2025 · 16 (35) · 15815-15835
DOI: 10.1039/d5sc04657b ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemical Science, 2025. Verfasst von Ruth Nussinov und 2 weiteren Autor:innen. Beteiligte Einrichtung: Computational Structural Biology Section, Frederick National Laboratory for Cancer Research MD 21702 USA NussinoR@mail.nih.gov. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: NCI NIH HHS, Intramural NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
In the MAPK and PI3K pathways, upstream kinases Raf, MEK, and PI3K have one primary substrate, while downstream kinases ERK, AKT, and mTOR have multiple substrates. Mutations in PI3K/AKT/mTOR kinases are more abundant than mutations in MAPK kinases.
Autor:innen und Institutionen
- Computational Structural Biology Section, Frederick National Laboratory for Cancer Research MD 21702 USA NussinoR@mail.nih.gov.
- Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University Tel Aviv 69978 Israel.
- Cancer Innovation Laboratory, National Cancer Institute at Frederick Frederick MD 21702 USA.
ORCID-Profile: Ruth Nussinov, Hyunbum Jang
Förderung
- NCI NIH HHS
- Intramural NIH HHS
- National Cancer Institute
Zitieren
APA
Nussinov, R., Regev, C., & Jang, H. (2025). Kinase signaling cascades: an updated mechanistic landscape. Chemical Science, 16(35), 15815-15835. https://doi.org/10.1039/d5sc04657b
Vancouver
Nussinov R, Regev C, Jang H. Kinase signaling cascades: an updated mechanistic landscape. Chemical Science. 2025;16(35):15815-15835. doi:10.1039/d5sc04657b
BibTeX
@article{Nussinov2025,
author = {Nussinov, Ruth and Regev, Clil and Jang, Hyunbum},
title = {Kinase signaling cascades: an updated mechanistic landscape},
journal = {Chemical Science},
year = {2025},
volume = {16},
number = {35},
pages = {15815--15835},
doi = {10.1039/d5sc04657b}
}
EUVIMED